We are live on
!
Find out more
VP
venBio Partners Portfolio holdings
AUM
$281M
1-Year Est. Return
261.03%
This Fund
S&P 500
This Quarter
Est. Return
-10.91%
1 Year Est. Return
+261.03%
3 Year Est. Return
+648.19%
5 Year Est. Return
+623.84%
10 Year Est. Return
–
AUM
$451M
AUM Growth
-$104M
(-19%)
Cap. Flow
-$8.13M
Cap. Flow
% of AUM
-1.8%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
1
Increased
–
Reduced
1
Closed
–
Top Buys
| 1 |
CINC
CinCor Pharma, Inc. Common Stock
CINC
|
+$40.6M |
Top Sells
| 1 |
Harmony Biosciences
HRMY
|
+$48.8M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
ALX Oncology
ALXO
$269M
| $164M | 36.34% |
9,699,925
| – | – |
|
|
2
Harmony Biosciences
HRMY
$1.93B
| $75.1M | 16.66% |
1,544,484
-1,195,927
| -44% | -$48.8M |
|
|
VTYX
3
DELISTED
Ventyx Biosciences
VTYX
| $68M | 15.08% |
5,011,536
| – | – |
|
4
Pharvaris
PHVS
$2.36B
| $41.8M | 9.26% |
2,303,310
| – | – |
|
|
CINC
5
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
| $34.7M | 7.7% |
+1,980,706
| New | +$40.6M |
|
|
AKRO
6
DELISTED
Akero Therapeutics
AKRO
| $30.8M | 6.83% |
2,171,664
| – | – |
|
|
IMPL
7
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
| $17.6M | 3.9% |
2,759,791
| – | – |
|
|
CMPI
8
DELISTED
Checkmate Pharmaceuticals, Inc. Common Stock
CMPI
| $11.7M | 2.6% |
3,673,374
| – | – |
|
|
ELEV
9
DELISTED
Elevation Oncology
ELEV
| $6.57M | 1.46% |
2,608,167
| – | – |
|
|
VRNA
10
DELISTED
Verona Pharma
VRNA
| $808K | 0.18% |
161,897
| – | – |
|
Similar funds
OCWP
FFP
BDA
PHC
OFCM
SA
ACC
NRCM